Do pregnancies with pre-eclampsia have smaller placentas? A population study of 317688 pregnancies with and without growth restriction in the offspring

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 12, 2010, Pages 1521-1526

  Eskild, A ^a,b   Vatten, L J ^c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Placental weight; population study; pre eclampsia; small for gestational age

Indexed keywords

ARTICLE; BIRTH WEIGHT; FEMALE; HUMAN; NORWAY; PLACENTA DISORDER; PLACENTA WEIGHT; POPULATION RESEARCH; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGENY; SMALL FOR DATE INFANT;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; ORGAN SIZE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 78349259375     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02701.x     Document Type: Article

References (26)

1. Roberts JM, Lain KY,. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002; 23: 359 - 72.
2. Vatten LJ, Skjaerven R,. Is pre-eclampsia more than one disease? BJOG 2004; 111: 298 - 302.
3. Salafia CM, Charles AK, Maas EM,. Placenta and fetal growth restriction. Clin Obstet Gynecol 2006; 49: 236 - 56.
4. Ness RB, Sibai BM,. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40 - 9.
5. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD,. Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta? Placenta 2006; 27: 727 - 34.
6. Harrington K, Cooper D, Lees C, Hecher K, Campbell S,. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational- age baby. Ultrasound Obstet Gynecol 1996; 7: 182 - 8.
7. Mayhew TM, Charnock-Jones DS, Kaufmann P,. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004; 25: 127 - 39.
8. Thame M, Osmond C, Bennett F, Wilks R, Forrester T,. Fetal growth is directly related to maternal anthropometry and placental volume. Eur J Clin Nutr 2004; 58: 894 - 900.
9. Myatt L,. Role of the placenta in preeclampsia. Endocrine 2002; 19: 103 - 11.
10. Eskild A, Romundstad PR, Vatten LJ,. Placental weight and birth weight: does the association differ between pregnancies with and without preeclampsia? Am J Obstet Gynecol 2009; 201: 595.e1 - 5.
11. Irgens LM,. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30years. Acta Obstet Gynecol Scand 2000; 79: 435 - 9.
12. Harlow FH, Brown MA,. The diversity of diagnoses of preeclampsia. Hypertens Pregnancy 2001; 20: 57 - 67.
13. Roberts JM, Pearson G, Cutler J, Lindheimer M,; NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437 - 45.
14. Zetterström K, Lindeberg SN, Haglund B, Hanson U,. The association of maternal chronic hypertension with perinatal death in male and female offspring: a record linkage study of 866,188 women. BJOG 2008; 115: 1436 - 42.
15. Royal College of Obstetrics and Gynaecologists. Preeclampsia study group consensuses statement. 2003. []. Last accessed 11 August 2010.
16. Thompson JM, Irgens LM, Skjaerven R, Rasmussen S,. Placenta weight percentile curves for singleton deliveries. BJOG 2007; 114: 715 - 20.
17. Dahlstrøm BL, Romundstad P, ian P, Vatten LJ, Eskild A,. Placenta weight in preeclampsia. Acta Obstet Gynecol Scand 2008; 87: 608 - 11.
18. Naeye RL,. Disorders of the Placenta, Fetus, and Neonate: Diagnosis and Clinical Significance. St. Louis: Mosby Year Book, 1992, 132.
19. Benirschke K, Kaufmann P,. Placenta shape aberrations. In:, Benirschke K, Kaufmann P, editors. Pathology of the Human Placenta, 4th edn. New York: Springer; 2000. pp. 401 - 4.
20. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, etal. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672 - 83.
21. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC,. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007; 196: 239 - 6.
22. Wathen KA, Tuutti E, Stenman UH, Alfthan H, Halmesmaki E, Finne P, etal. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 2006; 91: 180 - 4.
23. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, etal. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9 - 23.
24. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, etal. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90: 4895 - 903.
25. Ness RB, Roberts JM,. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175: 1365 - 70.
26. Roberts JM, Catov JM,. Preeclampsia more than 1 disease or is it? Hypertension 2008; 51: 989 - 90.